Cerebral palsy: New pathogenetic concepts;Parálisis cerebral: Nuevos conceptos etiopatogénicos

Revista de Neurologia

Volumn 36, Issue 2, 2003, Pages 157-165

  Legido, Agustin ^a   Katsetos, C D ^a  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

Cerebral palsy; Cytokines; Hypocapnia; Leiden mutation; Oligodendrocyte; Pathogenesis; Periventricular leukomalacia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; CYTOKINE; FREE RADICAL; GLUTAMIC ACID; INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

BRAIN ISCHEMIA; BRAIN VENTRICLE HEMORRHAGE; CELL MATURATION; CEREBRAL PALSY; COGNITIVE DEFECT; CONFERENCE PAPER; GENE MUTATION; GENETIC DISORDER; HUMAN; HYPOCAPNIA; IMMUNITY; INFLAMMATION; INTRAUTERINE INFECTION; LEUKOMALACIA; MATERNAL DISEASE; NEUROPATHOLOGY; NEURORADIOLOGY; NEWBORN; OLIGODENDROGLIA; PREMATURITY; PREVALENCE; REPERFUSION INJURY;

EID: 0037448355     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3602.2002261     Document Type: Conference Paper

References (100)

1. Little W. On the influence of abnormal parturation, difficult labours, premature birth, and asphyxia neonatorum on the mental and physical condition of the child, especially in relation to deformities. Trans Obstet Soc London 1861; 3: 293.
2. Burgess D. A case of cerebral birth palsy. Med Chron Manchester 1888; 9: 471.
3. Freud S. Die infantile cerebrallahmung. In Nothnagel J, ed. Specialle Pathologie und Therapie. Band IX, Th. III. Vienna: Holder; 1897.
4. Miller G. Cerebral palsies: an overview. In Miller G, Clark GD, eds. The cerebral palsies. Boston: Butterworth-Heinemann; 1998. p. 1-35.
5. Scherzer AL. History, definition, and classification of cerebral palsy. In Scherzer, ed. Early diagnosis and interventional therapy in cerebral palsy. New York: Marcel Decker; 2001. p. 1-25.
6. Glass IA. X-linked mental retardation. J Med Genet 1991; 28: 361-71.
7. Gupta R, Appleton RE. Cerebral palsy: not always what it seems. Arch Dis Child 2001; 85: 356-60.
8. Gupta VB. Trends in etiology and epidemiology of cerebral palsy. In Scherzer, ed. Early diagnosis and interventional therapy in cerebral palsy. New York: Marcel Decker; 2001. p. 27-47.
9. Papazian O, Alfonso I. Terapia de la parálisis cerebral. Rev Neurol 1997; 25: 728-39.
10. Paneth N. Cerebral palsy in term infants-birth or before birth? J Pediatr 2001; 138: 791-2.
11. Sinha G, Corry P, Subesinghe D, Wild J, Levene MI. Prevalence and type of cerebral palsy in a British ethnic community: the role of consanguinity. Dev Med Child Neurol 1997; 39: 259-62.
12. Dolk H, Pattenden S, Johnson A. Cerebral palsy, low birthweight and socio-economic deprivation: inequalities in a major cause of childhood disability. Paediatr Perinat Epidemiol 2001; 15: 359-63.
13. Hagberg B, Hagberg G, Olow I. I. The changing panorama of cerebral palsy in Sweden. Acta Paediatr Scand 1984; 73: 433-40.
14. Hagberg B, Hagberg G, Zetterstrom R. Decreasing perinatal mortality: increase in cerebral palsy morbidity. Acta Paediatr Scand 1989; 78: 664-70.
15. Hagberg B, Hagberg G, Olow I, Von Wendt L. The changing panorama of cerebral palsy in Sweden. V: the birth year period 1979-82. Acta Paediatr Scand 1989; 78: 283-90.
16. Hagberg B, Hagberg G, Olow I, Von Wendt L. The changing panorama of cerebral palsy in Sweden. VI: Prevalence and origin during the birth year period 1983-86. Acta Paediatr Scand 1993; 82: 387-93.
17. Hagberg B, Hagberg G, Olow I, Von Wendt L. The changing panorama of cerebral palsy in Sweden. VII: Prevalence and origin in the birth year period 1987-90. Acta Paediatr Scand 1996; 85: 954-60.
18. Stanley FJ, Watson L. The cerebral palsies in Western Australia: trends 1968 to 1981. Am J Obstet Gynecol 1988; 158: 89-93.
19. Hagberg B. Lessons and indications from three decades of West-Swedish cerebral palsy data. Neuropediatrics 2000; 31: 284-6.
20. Bhushan V, Paneth N, Kiely JL. Impact of improved survival of very low birth infants on recent secular trends in the prevalence of cerebral palsy. Pediatrics 1993; 91: 1094-100.
21. Pharoah PO, Platt MJ, Cooke T. The changing epidemiology of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 1996; 75: 169-73.
22. Robertson CMT, Hrynchyshyn J, Etches PC, Pain KS. Population-based study of the incidence, complexity, and severity of neurologic disability among survivors weighing 500 through 1250 grams at birth: A comparison of two birth cohorts. Pediatrics 1992; 90: 750-5.
23. O'Shea TM, Preisser JS, Klinepeter KL, Dillard RG. Trends in mortality and cerebral palsy in a geographically based cohort of very low birth weight neonates born between 1982 to 1994. Pediatrics 1998; 101: 642-7.
24. Hughes I, Newton R. Genetic aspects of cerebral palsy. Dev Med Child Neurol 1992; 34: 80-6.
25. McHale DP, Mitchell S, Bundey L, Moynihan DA, Campbell DA, Woods CG, et al. A gene for autosomal recessive symmetrical spastic cerebral palsy maps to chromosome 2q24-25. Am J Hum Genet 1999; 64: S26-32.
26. Gustavson ML, Hagberg HB, Sanner G. Identical syndromes of cerebral palsy in the same family. Acta Paediatr Scand 1969; 58: 330-40.
27. Böök JA. A genetic and neuropsychiatric investigation of North Swedish population. Part II: Mental deficiency and convulsive disorders. Acta Genet Statist Med 1953; 4: 345-414.
28. Bundey S, Griffiths ML, Young JA. Recurrence risk of symmetrical spastic cerebral palsy. Dev Med Child Neurol 1978; 20: 390-1.
29. Seemanová E, Lesny I, Hyánek J, Brachfeld K, Rössler M, Proskova M. X-chromosome recessive microcephaly with epilepsy, spastic tetraplegia and absent abdominal reflex. New entity or 'Paine syndrome'? Humangenetik 1973; 20: 113-7.
30. Fletcher NA, Foley J. Parental age, genetic mutation, and cerebral palsy. J Med Genet 1993; 30: 44-6.
31. Amor DJ, Craig JA, Delatycki MB, Eddihough D. Genetic factors in athetoid cerebral palsy. J Child Neurol 2001; 16: 793-7.
32. Baar HS, Gabriel AM. Sex-linked spastic paraplegia. Am J Ment Defic 1966; 71: 13-8.
33. Zonana J, Adornato BT, Glass ST, Webb MJ. Familial porencephaly and congenital hemiplegia. J Pediatr 1986; 109: 671-4.
34. McHale DP, Jackson AP, Campbell DA, Levene MI, Corry P, Woods CG, et al. A gene for ataxic cerebral palsy maps to chromosome 9p 12-q12. Eur J Hum Genet 2000; 8: 267-72.
35. Martínez F, Tomas M, Millán JM, Fernández A, Palau F, Prieto F. Genetic localisation of mental retardation with spastic diplegia to the pericentromeric region of the X-chromosome: X inactivation in female carriers. J Med Genet 1998; 35: 284-7.
36. Shaffer LG, Benke PJ. Telomeric crossing. Am J Med Genet 1999; 87: 278-80.
37. Pessoa de Barros EMK, Rodrigues CJ, Pessoa de Barros TE, Bevilacqua RG. Presence of apolipoprotein E e4 allele in cerebral palsy. J Pediatr Orthop 2000; 20: 786-9.
38. Mayeux R, Ottman R, Maestre G, Ngai C, Tang MX, Ginsberg H, et al. Synergistic effects of traumatic brain injury and apolipoprotein ε in patients with Alzheimer's disease. Neurology 1995; 45: 555-7.
39. Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S. Apolipoprotein E ε4 associated with chronic traumatic bran injury in boxing. JAMA 1997; 278: 136-40.
40. Nelson KB, Broman SH. Perinatal risk factors in children with serious motor and mental handicaps. Ann Neurol 1977; 2: 371-7.
41. Nelson KB, Ellenberg JH. Neonatal signs predictors of cerebral palsy. Pediatrics 1979; 64: 225-32.
42. Sugimoto T, Woo M, Nishida N, Araki A, Hara T, Yasuhara A, et al. When do brain abnormalities in cerebral palsy occur? An MRI study. Dev Med Child Neurol 1995; 37: 285-92.
43. Thorarensen O, Ryan S, Hunter J, Younkin DP. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis. Ann Neurol 1997; 42: 372-5.
44. Lynch JK, Nelson KB, Curry CJ, Grether JK. Cerebrovascular disorders in children with the factor V Leiden mutation. J Child Neurol 2001; 16: 735-44.
45. Harum KH, Hoon AH, Casella JF, Breiter SN, Johnston MV. Homozygous factor-V mutation as a genetic cause of perinatal thrombosis and cerebral palsy. Dev Med Child Neurol 1999; 41: 777-80.
46. Harum KH, Hoon AH, Casella JF. Factor-V Leiden: a risk factor for cerebral palsy. Dev Med Child Neurol 1999; 41: 781-5.
47. Nelson KB, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998; 44: 665-75.
48. Halliday JL, Reddihough D, Byron K, Ekert H, Ditchfield M. Hemiplegic cerebral palsy and the factor V Leiden mutation. J Med Genet 2000; 37: 787-9.
49. Foster-Barber A, Dickens B, Ferriero DM. Human perinatal asphyxia: correlation of neonatal cytokines with MRI and outcome. Dev Neurosci 2001; 23: 213-8.
50. Grether JK, Nelson KB, Dambrosia JM, Phillips TM. Interferons and cerebral palsy. J Pediatr 1999; 134: 324-32.
51. Volpe JJ. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001; 50: 553-62.
52. Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Damman O, et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Pediatr Res 1999; 46: 566-75.
53. Dammann O, Durum S, Leviton A. Do white cells matter in white matter damage? Trends Neurosci 2001; 24: 320-4.
54. Gaudet L, Smith GN. Cerebral palsy and chorioamnionitis: The inflammatory cytokine link. Obstet Gynecol Surv 2001; 56: 433-6.
55. Schendel DE. Infection in pregnancy and cerebral palsy. JAMWA 2001; 56: 105-8.
56. Saliba E, Marret S. Cerebral white matter damage in the preterm infant: pathophysiology and risk factors. Sem Neonatol 2001; 6: 121-33.
57. Svigos JM. The fetal inflammatory response syndrome and cerebral palsy: yet another challenge and dilemma for the obstetrician. Aust NZ J Obstet Gynecol 2001; 41: 170-6.
58. Nelson KB, Willoughby RE. Infection, inflammation and the risk of cerebral palsy. Curr Op Neurol 2000; 13: 133-9.
59. Yoon BH, Jun JK, Romero R, Park H, Gómez R, Choi JH, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997; 177: 19-26.
60. Murphy DJ, Sellers S, MacKenzie IZ, Yudkin PL, Johnson AM. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet 1995; 346: 1449-54.
61. Gómez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179: 194-202.
62. Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182: 675-81.
63. Kumazaki K, Nakayama M, Sumida Y, Ozono K, Mushiake S, Suehara N, et al. Placental features in preterm infants with periventricular leukomalacia. Pediatrics 2002; 109: 650-5.
64. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997; 278: 207-11.
65. Wu YW, Colford JM. Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA 2000; 284: 1417-24.
66. Toti P, De Felice C. Chorioamnionitis and fetal/neonatal brain injury. Biol Neonate 2001; 79: 201-4.
67. Deguchi K, Mizguchi M, Takashima S. Immunohistochemical expression of tumor necrosis factor α in neonatal leukomalacia. Pediatr Neurol 14: 13-6.
68. Yoon BH, Romero R, Kim CJ, Koo JN, Choe G, Syn HC, et al. High expression of tumor necrosis facotor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet gynecol 1997; 177: 406-11.
69. Yoon BH, Kim CJ, Romero R, Jun JK, Park KH, Choi ST, et al. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol 1997; 177: 797-802.
70. Cai Z, Pan ZL, Pang Y, Evans OB, Rhodes PG. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 2000; 47: 64-72.
71. Pang Y, Cai Z, Rhodes PG. Effects of lipopolysaccharide on oligodendrocyte progenitor cells are mediated by astrocytes and microglia. J Neurosci Res 2000; 62: 510-20.
72. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, et al. The toll-like receptor TLRa is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 2002; 22: 2478-86.
73. Zhang G, Ghosh S. Toll-like receptor-mediated NF-kappa B activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001; 107: 13-9.
74. Burgmaier G, Schonrock LM, Kuhlmann T, Richter-Landsberg C, Bruck W. Association of increased BCL-2 expression with rescue from tumor necrosis factor-α induced cell death in the oligodendrocyte line OLN-93. J Neurochem 2000; 75: 2270-6.
75. Popko B, Baerwald KD. Oligodendroglial response to the immune cytokine interferon gamma. Neurochem Res 1999; 24: 331-8.
76. Andrews T, Zhang P, Bhat NR. TNFα potentiates IFNγ-induced cell death in oligodendrocyte progenitors. J Neurosci Res 1998; 54: 574-83.
77. Golden JA, Gilles FH, Rudelli R, Leviton A. Frequency of neuropathological abnormalities in very low birth weight infants. J Neuropathol Exp Neurol 1997; 56: 472-8.
78. Mabuchi T, Kitakawa K, Ohtsuki T, Kuwabara K, Yagita Y, Yanagihara T, et al. Contribution of microglia/macrophages to expansion of infarction and response of oligodendrocytes after focal cerebral ischemia in rats. Stroke 2000; 31: 1735-43.
79. Tahraoui SL, Marret S, Bodenant C, Leroux P, Dommergues MA, Evrard P, et al. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol 2001; 11: 56-71.
80. Kumar A, Short J, Parrilio JE. Genetic factors in septic shock. JAMA 1999; 282; 579-81.
81. Roberts AK, Monzón-Bordonaba F, Van Deerlin PG, Holder J, Macones GA, Morgan MA, et al. Association of polymorphism within the promoter of the tumor necrosis factor α gene with risk of preterm premature rupture of the fetal membranes. Am J Obstet Gynecol 1999; 180: 1297-302.
82. Legido A, Clancy RR, Berman PH. Neurologic outcome after EEG proven neonatal seizures. Pediatrics 1991; 88: 583-96.
83. Legido A. Perinatal hypoxic-ischemic encephalopathy: current advances in diagnosis and treatment. Int Pediatr 1994; 9: 114-36.
84. Vexler ZS, Ferriero DM. Molecular and biochemical mechanisms of perinatal brain injury. Semin Neonatol 2001; 6: 99-108.
85. Volpe JJ. Perinatal brain injury: From pathogenesis to neuroprotection. Mental Retard Dev Disabil Res Rev 2001; 7: 56-64.
86. Du Plessis AJ, Volpe JJ. Perinatal brain injury in the preterm and term newborn. Curr Op Neurol 2002; 15: 151-7.
87. Greisen G, Vannucci RC. Is periventricular leukomalacia a result of hypoxic-ischaemic injury? Biol Neonate 2001; 79: 194-200.
88. Vannucci RC, Brucklacher RM, Vannuci SJ. Effect of carbon dioxide on central metabolism during hypoxia-ischemia in the immature rat. Pediatr Res 1997; 42: 24-9.
89. Fritz KI, Ashraf QM, Mishra OP, Delivoria-Papadopoulos M. Effect of moderate hypocapnic ventilation on nuclear DNA fragmentation and energy metabolism in the cerebral cortex of newborn piglets. Pediatr Res 2001; 50: 586-9.
90. Graziani LJ, Spitzer AR, Mitchell DG, Merton DA, Stanley C, Robinson N, et al. Mechanical ventilation in preterm infants: neurosonographic and developmental studies. Pediatrics 1992; 90: 515-22.
91. Fujimoto S, Togari H, Yamaguchi N, Mizutani F, Suzuki S, Sobajima H. Hypocarbia and cystic periventricular leukomalacia in premature infants. Arch Dis Child 1994; 71: F107-10.
92. Ikonen RS, Janas MO, Koivikko MJ. Hyperbilirubinemia, hypocarbia and periventricular leukomalacia in preterm infants: relationship to cerebral palsy. Acta Paediatr 1992; 81: 802-7.
93. Collins MP, Lorenz JM, Jetton JR, Paneth N. Hypocapnia and other ventilation-related-risk factors for cerebral palsy in low birth weight infants. Pediatr Res 2001; 50: 712-9.
94. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 1998; 18: 6241-53.
95. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001; 21: 1302-12.
96. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002; 22: 455-63.
97. Back SA, Luo NL, Borenstein NS, Volpe JJ, Kinney HC. Arrested oligodendrocyte lineage progression during central white matter development: dissociation between the timing of progenitor differentiation and myelinogenesis. J Neuropathol Exper Neurol 2002; 61: 197-211.
98. Inder TE, Huppi PS, Warfield S, Kikinis R, Zientara GP, Barnes PD, et al. Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term. Ann Neurol 1999; 46: 755-60.
99. Marín-Padilla M. Developmental neuropathology and impact of perinatal brain damage. II. White matter lesions of the neocortex. J Neuropathol Exp Neurol 1997; 56: 219-35.
100. Legido A, Khurana P, De Chadarevian JP, Katsetos CD. Loss of calbindinergic neural precursors in the human ganglionic eminence during intraventricular hemorrhage: neuropathological implications (abstract). Ann Neurol [in press].